This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: Nof Corporation. Active years: 2010-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2010-2012
Title: Hiroshi Kurosawa: Innovator in Embryoid Body Formation
Introduction
Hiroshi Kurosawa is a notable inventor based in Koufu, Japan. He has made significant contributions to the field of embryoid body formation, particularly through his innovative methods and techniques. With a total of 2 patents to his name, Kurosawa continues to push the boundaries of scientific research and application.
Latest Patents
Kurosawa's latest patents include a "Method for forming embryoid bodies" and a "Container for germ layer formation and method of forming germ layer." The first patent relates to a vessel designed for embryoid formation, which allows for the easy formation of embryoid bodies from embryonic stem (ES) cells without complicated techniques. The method involves providing a vessel with a coating layer made from a compound featuring a specific PC-like group on its surface, which defines a region for the floating culture of ES cells. The process includes floating culturing ES cells in the vessel to facilitate the formation of embryoid bodies.
Career Highlights
Kurosawa is currently associated with Nof Corporation, where he applies his expertise in developing innovative solutions in the field of biotechnology. His work has garnered attention for its potential applications in regenerative medicine and developmental biology.
Collaborations
Kurosawa collaborates with Shujiro Sakaki, a fellow researcher, to further enhance the research and development of their innovative methods. Their partnership exemplifies the importance of teamwork in advancing scientific discoveries.
Conclusion
Hiroshi Kurosawa's contributions to the field of embryoid body formation highlight his innovative spirit and dedication to scientific advancement. His patents reflect a commitment to simplifying complex processes in biotechnology, paving the way for future research and applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
